News
GHSI
8.00
-1.72%
-0.14
Weekly Report: what happened at GHSI last week (0422-0426)?
Weekly Report · 6d ago
Weekly Report: what happened at GHSI last week (0415-0419)?
Weekly Report · 04/22 10:23
Weekly Report: what happened at GHSI last week (0408-0412)?
Weekly Report · 04/15 10:17
Guardion Health Sciences Updates Executive Compensation Plans
TipRanks · 04/09 20:43
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session. The company missed third-quarter estimates and said it no longer expects to generate positive free cash flow for the full fiscal year 2024. Laser Photonics Corporation shares climbed 168% to $3.82.
Benzinga · 04/09 17:12
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector +0.11% to 1666.38. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 04/09 14:00
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out on Tuesday morning. Biophytis stock is rocketing close to 50% after announcing its 2023 results. Moving stocks this morning are earnings reports, clinical trial data and more. Biggest Pre-Market Stock Movers include 10 top gainers and 10 top losers.
Investorplace · 04/09 11:27
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Biophytis S.A. Posted a FY23 loss of €0.03 per share. MyMD Pharmaceuticals, Inc. Shares rose 40% in pre-market trading after jumping 22% on Monday. Biophytis shares jumped 55.2% to $0.4920 in today's pre- market trading.
Benzinga · 04/09 10:05
Weekly Report: what happened at GHSI last week (0401-0405)?
Weekly Report · 04/08 10:20
Guardion Health Sciences files to sell 690,100 shares of common stock
Guardion Health Sciences, Inc. Files to sell 690,100 shares of common stock. The company filed a prospectus related to the offer and sale of the stock. This prospectus is not an offer to sell. Health Sciences filed to sell the stock in 2024.
Seeking Alpha · 04/02 20:28
Weekly Report: what happened at GHSI last week (0325-0329)?
Weekly Report · 04/01 10:19
Guardion Health Swings To Annual Net Profit, Revenue Improves
NASDAQ · 03/29 11:19
Guardion Health Sciences GAAP EPS of $0.12, revenue of $12.25M
Guardion Health Sciences reports FY GAAP EPS of $0.12, revenue of $12.25M (+10.9% Y/Y) Viactiv product line generated net revenues of $11.9M for the year ended December 31, 2023.
Seeking Alpha · 03/29 10:49
*Guardion Health Sciences 2023 Rev $12.2M >GHSI
Dow Jones · 03/29 10:15
*Guardion Health Sciences 2023 EPS 12c >GHSI
Dow Jones · 03/29 10:15
Weekly Report: what happened at GHSI last week (0318-0322)?
Weekly Report · 03/25 10:21
Weekly Report: what happened at GHSI last week (0311-0315)?
Weekly Report · 03/18 10:20
Weekly Report: what happened at GHSI last week (0304-0308)?
Weekly Report · 03/11 10:18
Weekly Report: what happened at GHSI last week (0226-0301)?
Weekly Report · 03/04 10:20
Weekly Report: what happened at GHSI last week (0219-0223)?
Weekly Report · 02/26 10:27
More
Webull provides a variety of real-time GHSI stock news. You can receive the latest news about Guardion Health Sciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About GHSI
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplements for bone health and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel flavored calcium chews constitute the main product category. It also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The Company's GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress.